home / stock / surf / surf news

SURF News and Press, Surface Oncology Inc. From 05/09/19

Stock Information
Company Name: Surface Oncology Inc.
Stock Symbol: SURF
Market: NASDAQ
Website: surfaceoncology.com
Menu
SURF SURF Quote SURF Short SURF News SURF Articles SURF Message Board
Get SURF Alerts

News, Short Squeeze, Breakout and More Instantly...
SURF - Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2019

CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today reported financial results and corporate highlights for the first quarter of...
SURF - Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day

CAMBRIDGE, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Surface Oncology  (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, chief executive officer, will be partic...

SURF - Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer

CAMBRIDGE, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Surface Oncology  (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced the appointment of Wendy Dwyer as chief business officer....

SURF - Microcaps tops midday movers

Gainers:  Estre Ambiental (NASDAQ: ESTR ) +81% . Motif Bio plc (NASDAQ: MTFB ) +71% . Nevro (NYSE: NVRO ) +33% . Electrameccanica Vehicles (NASDAQ: SOLO ) +32% . Dragon Victory International (NASDAQ: LYL ) +21% . Fibrocell Science (NASDAQ: FCSC ) +18% . Amira Nature Foods (NYSE:...
SURF - Surface Oncology (SURF) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow

The following slide deck was published by Surface Oncology, Inc. in conjunction with this Read more ...

SURF - Surface Oncology beats on revenue

Surface Oncology (NASDAQ: SURF ): Q4 GAAP EPS of -$0.17. More news on: Surface Oncology, Earnings news and commentary, Healthcare stocks news, , Read more ...

SURF - Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2018

CAMBRIDGE, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Surface Oncology   (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today reported financial results and corporate highlights for the fourt...
SURF - Surface Oncology to Present at the 39th Annual Cowen Healthcare Conference

CAMBRIDGE, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, chief executive officer, will provide a corpora...

SURF - Surface Oncology Retains Worldwide Rights for its First-in-Class Antibody Targeting IL-27, SRF388

IL-27 is a key regulator of checkpoint protein expression SRF388 believed to be the only anti-IL-27 targeted agent in late-preclinical development Investigational New Drug (IND) submission for SRF388 expected in Q4 2019 CAMBRIDGE, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Surface On...

SURF - Surface Oncology Announces Appointment of F. Stephen Hodi, MD to its Scientific Advisory Board

CAMBRIDGE, Mass., Jan. 04, 2019 (GLOBE NEWSWIRE) -- Surface Oncology  (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced the appointment of the F. Stephen Hodi, MD to the company&#...
Previous 10 Next 10